rs148908731

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS2

The NM_000815.5(GABRD):​c.775G>A​(p.Val259Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000102 in 1,566,038 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V259V) has been classified as Benign.

Frequency

Genomes: 𝑓 0.00039 ( 1 hom., cov: 34)
Exomes 𝑓: 0.000071 ( 0 hom. )

Consequence

GABRD
NM_000815.5 missense

Scores

11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 0.991

Publications

3 publications found
Variant links:
Genes affected
GABRD (HGNC:4084): (gamma-aminobutyric acid type A receptor subunit delta) Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. The GABA-A receptor is generally pentameric and there are five types of subunits: alpha, beta, gamma, delta, and rho. This gene encodes the delta subunit. Mutations in this gene have been associated with susceptibility to generalized epilepsy with febrile seizures, type 5. Alternatively spliced transcript variants have been described for this gene, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
GABRD Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics, ClinGen
  • epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • epilepsy, idiopathic generalized, susceptibility to, 10
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 3 uncertain in NM_000815.5
BP4
Computational evidence support a benign effect (MetaRNN=0.008660853).
BP6
Variant 1-2029194-G-A is Benign according to our data. Variant chr1-2029194-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 235308.
BS2
High AC in GnomAd4 at 60 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GABRDNM_000815.5 linkc.775G>A p.Val259Ile missense_variant Exon 7 of 9 ENST00000378585.7 NP_000806.2
GABRDXM_017000936.2 linkc.1480G>A p.Val494Ile missense_variant Exon 6 of 8 XP_016856425.1
GABRDXM_011541194.4 linkc.814G>A p.Val272Ile missense_variant Exon 7 of 9 XP_011539496.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GABRDENST00000378585.7 linkc.775G>A p.Val259Ile missense_variant Exon 7 of 9 1 NM_000815.5 ENSP00000367848.4

Frequencies

GnomAD3 genomes
AF:
0.000394
AC:
60
AN:
152246
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.0000890
AC:
16
AN:
179708
AF XY:
0.0000942
show subpopulations
Gnomad AFR exome
AF:
0.000664
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000230
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000526
Gnomad OTH exome
AF:
0.000404
GnomAD4 exome
AF:
0.0000707
AC:
100
AN:
1413674
Hom.:
0
Cov.:
31
AF XY:
0.0000587
AC XY:
41
AN XY:
699056
show subpopulations
African (AFR)
AF:
0.000654
AC:
21
AN:
32102
American (AMR)
AF:
0.000108
AC:
4
AN:
37180
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25430
East Asian (EAS)
AF:
0.000108
AC:
4
AN:
36902
South Asian (SAS)
AF:
0.0000249
AC:
2
AN:
80454
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48090
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5720
European-Non Finnish (NFE)
AF:
0.0000533
AC:
58
AN:
1088940
Other (OTH)
AF:
0.000170
AC:
10
AN:
58856
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000394
AC:
60
AN:
152364
Hom.:
1
Cov.:
34
AF XY:
0.000336
AC XY:
25
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.00113
AC:
47
AN:
41582
American (AMR)
AF:
0.000261
AC:
4
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68034
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000166
Hom.:
1
Bravo
AF:
0.000487
ESP6500AA
AF:
0.00137
AC:
6
ESP6500EA
AF:
0.000117
AC:
1
ExAC
AF:
0.000144
AC:
17
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Feb 01, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

EEG abnormality Uncertain:1
Sep 02, 2016
Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

GABRD-related disorder Benign:1
Dec 20, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Idiopathic generalized epilepsy Benign:1
Nov 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.059
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
0.32
DANN
Benign
0.69
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.31
T
M_CAP
Benign
0.054
D
MetaRNN
Benign
0.0087
T
PhyloP100
0.99
ClinPred
0.0022
T
GERP RS
-3.2
Varity_R
0.019
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148908731; hg19: chr1-1960633; API